News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
386,350 Results
Type
Article (26263)
Company Profile (60)
Press Release (360027)
Multimedia
Podcasts (26)
Webinars (7)
Section
Business (105641)
Career Advice (451)
Deals (17207)
Drug Delivery (51)
Drug Development (47984)
Employer Resources (47)
FDA (12292)
Job Trends (8497)
News (188065)
Policy (19580)
Tag
Academia (1766)
Accelerated approval (3)
Adcomms (8)
Allergies (74)
Alliances (27360)
ALS (57)
Alzheimer's disease (815)
Antibody-drug conjugate (ADC) (57)
Approvals (12356)
Artificial intelligence (175)
Autoimmune disease (10)
Automation (4)
Bankruptcy (144)
Best Places to Work (6925)
BIOSECURE Act (5)
Biosimilars (39)
Biotechnology (40)
Bladder cancer (59)
Brain cancer (17)
Breast cancer (206)
Cancer (1492)
Cardiovascular disease (125)
Career advice (408)
Career pathing (13)
CAR-T (80)
Cell therapy (216)
Cervical cancer (14)
Clinical research (40859)
Collaboration (474)
Compensation (134)
Complete response letters (9)
COVID-19 (1514)
CRISPR (15)
C-suite (148)
Cystic fibrosis (43)
Data (1604)
Decentralized trials (2)
Denatured (18)
Depression (31)
Diabetes (181)
Diagnostics (3551)
Digital health (11)
Diversity (5)
Diversity, equity & inclusion (13)
Drug discovery (52)
Drug pricing (55)
Drug shortages (21)
Duchenne muscular dystrophy (56)
Earnings (37390)
Editorial (22)
Employer branding (6)
Employer resources (44)
Events (52534)
Executive appointments (456)
FDA (13354)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (3)
Frontotemporal dementia (3)
Funding (418)
Gene editing (47)
Generative AI (10)
Gene therapy (135)
GLP-1 (416)
Government (3051)
Grass and pollen (3)
Guidances (93)
Healthcare (12256)
Huntington's disease (10)
IgA nephropathy (16)
Immunology and inflammation (42)
Indications (20)
Infectious disease (1588)
Inflammatory bowel disease (82)
Inflation Reduction Act (4)
Influenza (28)
Intellectual property (52)
Interviews (40)
IPO (7158)
IRA (19)
Job creations (1863)
Job search strategy (379)
Kidney cancer (7)
Labor market (13)
Layoffs (176)
Leadership (4)
Legal (3665)
Liver cancer (57)
Lung cancer (237)
Lymphoma (102)
Machine learning (4)
Management (17)
Manufacturing (113)
MASH (53)
Medical device (12928)
Medtech (12931)
Mergers & acquisitions (10350)
Metabolic disorders (452)
Multiple sclerosis (56)
NASH (11)
Neurodegenerative disease (49)
Neuropsychiatric disorders (9)
Neuroscience (1157)
NextGen: Class of 2025 (3952)
Non-profit (2826)
Now hiring (17)
Obesity (227)
Opinion (70)
Ovarian cancer (58)
Pain (66)
Pancreatic cancer (56)
Parkinson's disease (90)
Partnered (11)
Patents (118)
Patient recruitment (85)
Peanut (37)
People (34993)
Pharmaceutical (17)
Pharmacy benefit managers (12)
Phase I (11780)
Phase II (17674)
Phase III (14484)
Pipeline (770)
Policy (63)
Postmarket research (1669)
Preclinical (3680)
Press Release (18)
Prostate cancer (77)
Psychedelics (17)
Radiopharmaceuticals (162)
Rare diseases (188)
Real estate (3028)
Recruiting (16)
Regulatory (14361)
Reports (17)
Research institute (1623)
Resumes & cover letters (48)
Rett syndrome (2)
RNA editing (2)
RSV (20)
Schizophrenia (52)
Series A (69)
Series B (50)
Service/supplier (3)
Sickle cell disease (22)
Special edition (4)
Spinal muscular atrophy (102)
Sponsored (13)
Startups (2162)
Stomach cancer (9)
Supply chain (39)
Tariffs (15)
The Weekly (8)
Vaccines (365)
Venture capitalists (14)
Weight loss (145)
Women's health (18)
Worklife (4)
Date
Last 7 days (480)
Last 30 days (1578)
Last 365 days (18461)
2025 (6463)
2024 (20077)
2023 (23029)
2022 (31032)
2021 (33327)
2020 (32495)
2019 (28664)
2018 (22009)
2017 (19139)
2016 (18272)
2015 (21396)
2014 (16169)
2013 (13406)
2012 (14569)
2011 (14860)
2010 (13301)
Location
Africa (358)
Alabama (17)
Alaska (2)
Arizona (119)
Arkansas (10)
Asia (26861)
Australia (3916)
California (3179)
Canada (1248)
China (448)
Colorado (167)
Connecticut (175)
Delaware (122)
Europe (48565)
Florida (563)
Georgia (129)
Idaho (33)
Illinois (364)
India (14)
Indiana (229)
Iowa (3)
Japan (127)
Kansas (74)
Kentucky (12)
Louisiana (8)
Maine (27)
Maryland (651)
Massachusetts (2221)
Michigan (108)
Minnesota (277)
Mississippi (2)
Missouri (52)
Montana (18)
Nebraska (18)
Nevada (35)
New Hampshire (60)
New Jersey (1169)
New Mexico (9)
New York (1018)
North Carolina (566)
North Dakota (4)
Northern California (1400)
Ohio (134)
Oklahoma (3)
Oregon (23)
Pennsylvania (867)
Puerto Rico (7)
Rhode Island (24)
South America (526)
South Carolina (23)
Southern California (1223)
Tennessee (79)
Texas (564)
United States (13260)
Utah (115)
Virginia (82)
Washington D.C. (42)
Washington State (234)
West Virginia (3)
Wisconsin (43)
386,350 Results for "shanghai sanyou medical".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Sanyou Bio: Sanyou’s Intelligence-Enabled Innovative Biologics R&D Platform Leads in the New Era of Biological Drug Development
Dr. Guojun Lang, founder and CEO of Sanyou Biopharmaceuticals provides industry insights.
March 27, 2024
·
17 min read
Sanyou Biopharmaceuticals Launches Advanced Intelligent R&D Service Platform
Sanyou Biopharmaceutical Co., Ltd. is delighted to announce the official launch of the “Sanyou Intelligent Innovative Biologics R&D Service Platform,” representing a transformative advancement in biopharmaceutical research and development.
March 12, 2024
·
2 min read
Press Releases
WORK Medical Technology Group LTD Announces Strategic Partnership with Shanghai Chartwell Medical Device Co., Ltd.
March 3, 2025
·
5 min read
Business
Sanyou Bio and BioGeometry join forces to create a next-generation Antibody Drug Discovery Platform driven by AIGC
Recently, BioGeometry and Sanyou Bio jointly announced the signing of a strategic partnership agreement.
March 18, 2024
·
6 min read
Sanyou’s “STAL Platform” is a significant advancement in the field of drug discovery.
Sanyou’s “STAL Innovative Biologics Drug Discovery Platform” is a significant advancement in the field of drug discovery.
November 17, 2023
·
2 min read
Policy
Congratulations to Sanyou Bio for achieving ISO9001 & IPMS certifications
Sanyou Biopharmaceuticals Co., Ltd is pleased to announce in October 2023, we have obtained ISO 9001 and IPMS certifications.
October 17, 2023
·
3 min read
Press Releases
Alligator Bioscience Announces Initiation of HLX22 Phase 2 Trial in Breast Cancer by Shanghai Henlius Biotech, Inc.
April 23, 2025
·
1 min read
Sanyou launches new European offices and continues to promote global business landscape
Headquartered in Shanghai China, Sanyou Biopharmaceuticals Co., Ltd. is a world-leading national high-tech biotechnology enterprise focusing on R&D and services of innovative biological drugs.
June 3, 2023
·
2 min read
Press Releases
MEDSIR, Featured Company at the Shanghai International Medical Oncology Symposium (7th SIMOS)
December 3, 2024
·
4 min read
Double Honors: Sanyou Bio Earns “Most Trusted Biopharmaceutical CXO Partner” and “Most Influential Partner of the Year” Awards
Sanyou Bio’s consecutive wins reflect our clients’ trust, and our proven track record, raising expectations for our future.
September 20, 2023
·
2 min read
1 of 38,635
Next
